Designs and develops high throughput mutagenesis technologies for studying functional genomics in mammalian systems. Lexicon went public in June 2000 (NASDAQ:LEXG).
Lexicon
![Lexicon](http://baycitycapital.com/wp-content/uploads/2014/04/portfolio-lexicon.jpg)
Designs and develops high throughput mutagenesis technologies for studying functional genomics in mammalian systems. Lexicon went public in June 2000 (NASDAQ:LEXG).